For example, Li et al. discovered that circARNT2 might control cisplatin resistance through the miR-155-5p/PDK1 pathway and has therapeutic potential for overcoming cisplatin resistance in HCC [25]. The gene discussed is PDK1; the disease is hepatocellular carcinoma.